Navigation Links
Poorer Patients Have Poorer Survival After Cancer Diagnosis
Date:6/23/2008

Less affluent individuals had more advanced disease and were less likely to receive needed treatment

MONDAY, June 23 (HealthDay News) -- Low socioeconomic status increases a cancer patient's risk of dying, say U.S. researchers who analyzed data on almost 14,000 breast, prostate and colorectal patients in seven states.

The study found that cancer patients with low socioeconomic status had more advanced cancers at time of diagnosis, received less aggressive treatment, and had a higher risk of dying within five years of diagnosis.

For example:

  • Poorer women were less likely to receive radiation treatment after a lumpectomy or to receive anti-estrogen therapy when diagnosed with an estrogen receptor-positive (ER+) tumor.
  • Prostate cancer patients who lived in less affluent areas were less likely to have a prostatectomy or receive radiation treatment than men who lived in areas of high socioeconomic status.
  • Colorectal cancer patients of low socioeconomic status were less likely to receive chemotherapy.

While blacks and Hispanic patients were more likely than whites to live in poorer areas, but the link between increased risk of cancer death and low socioeconomic status applied to all racial and ethnic groups.

However, this was not true for patients 65 and older, perhaps because they have more universal access to cancer screening and treatment via Medicare, regardless of socioeconomic status, the researchers said.

"These findings support the need to focus on socioeconomic status as an important underlying factor in cancer disparities by race and ethnicity," wrote Dr. Tim Byers, of the University of Colorado Denver, and colleagues.

"We need better information on how access to health care contributes to differences in cancer outcomes by socioeconomic status in order to address the root causes of racial and ethnic cancer disparities in the United States," they added.

The study is published in the Aug. 1 issue of the journal Cancer.

Another study in the same issue found that initiatives designed to increase awareness and use of breast cancer screening may improve breast cancer survival rates for black American women, who have a higher risk of death from the disease than white women.

Researchers in Atlanta looked at the impact on black women of a program that included public education about the importance of mammography screening, breast self-exams, and seeing a trained health care provider. The program also included breast cancer survivors who supported newly-diagnosed breast cancer patients by encouraging them to follow-up with recommended medical care and helping them access financial, transportation and support services.

Between 2001 and 2004, the program conducted 1,148 community interventions for more than 10,000 participants. During that time, a total of 487 women were diagnosed and treated for breast cancer (89 percent black, 5 percent white, 2 percent Hispanic, and 4 percent other race/ethnicity) at the AVON Comprehensive Breast Center at the Georgia Cancer Center for Excellence at Grady Memorial Hospital in Atlanta.

Over the study period, the proportion of Stage 0 (early) non-invasive breast cancers increased from 12.4 percent to 25.8 percent, and the proportion of Stage IV (late) invasive breast cancers decreased from 16.8 percent to 9.4 percent.

More information

The U.S. Centers for Disease Control and Prevention has more about eliminating disparities in cancer screening and management.



-- Robert Preidt



SOURCE: Cancer, news release, June 23, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Antidepressants do work in depression while evidence for CBT is poorer say experts
2. Blacks Awaiting Lung Transplants Face Poorer Outcomes
3. Poorer Blood Pressure Control in Blacks With Heart Failure
4. UNC faculty and students to develop plan to get clean water in poorer homes
5. Journal SLEEP: disturbed sleep linked to poorer daytime function in older women
6. Cancer control in Europe works; now it is time to extend it to poorer countries
7. Poor indoor air quality means poorer health for patients with COPD
8. Drinking Often Spurs Move to Poorer Neighborhoods
9. Younger Patients Seeking More Aesthetic Treatments
10. Leukemia drug could save lives of stroke patients
11. FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... ORLANDO, FLORIDA (PRWEB) , ... April 24, 2017 ... ... of telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth ... compliment LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed ...
(Date:4/24/2017)... ... 24, 2017 , ... Ridgecrest Herbals makes it a point to lead the ... waste, and support renewable energy. They believe this is a crucial part of their ... for health issues, and maintain that destroying the environment in the pursuit of profit ...
(Date:4/24/2017)... ... April 24, 2017 , ... The bar for just about everything—apparel, ... inhabiting the rarified air of pop and film stardom.(1) Not to be left out ... the smile. Grins now run the gamut from being encrusted with jewels and precious ...
(Date:4/24/2017)... Washington (PRWEB) , ... April 24, 2017 , ... Sean ... OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which ... perhaps any other marketer in the last 25 years. , Now, due to changes ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ... ... rise from USD 20 Billion in 2015 to around USD 26 ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
Breaking Medicine Technology: